Ads by Google

Repros Therapeutics to raise $4.4 million in financing

Oct 12, 2009 (Datamonitor via COMTEX) --

Company: Repros Therapeutics Inc (RPRX)

Repros Therapeutics has entered into a definitive agreement with institutional investors to sell 3.5 million shares of its common stock at $1.27 per share for gross proceeds of approximately $4.4 million.

Repros Therapeutics focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. 

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Copyright (C) 2009 Datamonitor. All rights reserved

News Provided by COMTEX

Company: Repros Therapeutics Inc (RPRX)


Related terms: drugs, medical

Related Articles

A Three-Way Strategy on Repros Therapeutics
Oct 26, 2009
...Cap A Three-Way Strategy on Repros Therapeutics 1 comment by: optionMONSTER...Russell Options activity surged in Repros Therapeutics (RPRX) on Friday, less than...Articles A Three-Way Strategy on Repros Therapeutics Oct 26, 2009 Spectrum Pharma...

Auckland airport starts NZ$125m bond offer
Oct 29, 2009
...to offer NZ$125 million ($90 million) in bonds to help with its immediate financing needs. Retail and institutional investors are invited to buy the bonds that pay 7% interest per annum, the airport says in a New Zealand stock exchange...

Repros Therapeutics Announces Amendment of NIH Proellex(R) License - Zibb.com
Oct 28, 2009
...Officer on an as needed basis. About Repros Therapeutics Inc. Repros Therapeutics focuses on the development of oral small molecule...documents are available on request from Repros Therapeutics or at www.sec.gov. Repros disclaims...

Landry's Agrees to Fertitta Buyout Offer
Nov 3, 2009
...is completed. To the extent that a superior proposal solicited during this period leads to the execution of a definitive agreement, Landry's would be obligated to pay a $2.4 million break-up fee to Mr. Fertitta's acquisition company...